CryoPort

$44.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.04 (-2.27%) Today
-$0.70 (-1.57%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell CryoPort and other stocks, options, and ETFs commission-free!

About CYRX

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN. The listed name for CYRX is CryoPort, Inc. Common Stock.

CEO
Jerrell W. Shelton
Employees
125
Headquarters
Brentwood, Tennessee
Founded
1990
Market Cap
1.77B
Price-Earnings Ratio
Dividend Yield
Average Volume
1.11M
High Today
$47.39
Low Today
$43.77
Open Price
$47.39
Volume
697.73K
52 Week High
$63.36
52 Week Low
$13.01

Collections

CYRX Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 4, After Hours

You May Also Like